Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234166PMC
http://dx.doi.org/10.1111/srt.13252DOI Listing

Publication Analysis

Top Keywords

actn1 diagnosis
4
diagnosis cutaneous
4
cutaneous squamous
4
squamous cell
4
cell carcinoma
4
carcinoma continuation
4
continuation study
4
actn1
1
cutaneous
1
squamous
1

Similar Publications

α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairment.

Blood Adv

March 2025

Department of Hematology, Zhejiang Key Laboratory for Precision Diagnosis and Treatment of Hematological Malignancies, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Cytoskeletal remodeling and mitochondrial bioenergetics play important roles in thrombocytopoiesis and platelet function. Recently, α-actinin-1 mutations have been reported in patients with congenital macrothrombocytopenia. However, the role and underlying mechanism of α-actinin-1 in thrombocytopoiesis and platelet function remain elusive.

View Article and Find Full Text PDF

Background: While most thyroid nodules are benign, 7-15% are malignant. Patients with indeterminate thyroid nodules (specifically Bethesda IV/Thy3f) often undergo diagnostic hemithyroidectomy to reach a diagnosis on final histology. The aim of this study was to assess the feasibility of circulating large extracellular vesicles as diagnostic biomarkers in patients presenting with Thy3f thyroid nodules.

View Article and Find Full Text PDF

Alpha-actin-1 (ACTN1) is a cytoskeletal protein, and new evidence suggests that it is associated with tumor progression and prognosis. However, the expression of ACTN1 in thyroid carcinoma (THCA) and its biological functions are not fully understood. This study aimed to explore the expression and biological function of ACTN1 in THCA.

View Article and Find Full Text PDF

Gene-expression profile analysis to disclose diagnostics and therapeutics biomarkers for thyroid carcinoma.

Comput Biol Chem

December 2024

Bioinformatics Lab (Dry), Department of Statistics, University of Rajshahi, Rajshahi 6205, Bangladesh. Electronic address:

Article Synopsis
  • Thyroid carcinoma (THCA) is the most common endocrine cancer in the head and neck, with ongoing research investigating its genetic links and molecular mechanisms, which are still not fully understood.
  • While drug therapies are the main treatment for advanced THCA, many patients develop resistance over time, highlighting the need for multi-targeted drug therapies.
  • A study identified 80 differentially expressed genes related to THCA and pinpointed eight key genes (some upregulated, some downregulated) that could serve as potential biomarkers for diagnosis and prognosis.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how asthma affects naïve/memory lymphocyte proportions through CD26 levels, aiming to link asthma phenotype/severity with variations in CD26 among various lymphocyte populations.* -
  • Methods included flow cytometry analysis of blood samples from healthy and asthma patients to measure CD26 levels and characterize CD4CD26 T cell subsets, leading to the identification of four distinct inflammatory profiles.* -
  • Results showed that neutrophilic asthma had lower CD4CD26 cells correlated with inflammation, while eosinophilic asthma had expanded CD26 subsets, particularly in atopic patients, indicating a role in chronic inflammation associated with allergic asthma.*
View Article and Find Full Text PDF